{"pmid":32452417,"title":"New insights into the evolutionary features of viral overlapping genes by discriminant analysis.","text":["New insights into the evolutionary features of viral overlapping genes by discriminant analysis.","Overlapping genes originate by a mechanism of overprinting, in which nucleotide substitutions in a pre-existing frame induce the expression of a de novo protein from an alternative frame. In this study, I assembled a dataset of 319 viral overlapping genes, which included 82 overlaps whose expression is experimentally known and the respective 237 homologs. Principal component analysis revealed that overlapping genes have a common pattern of nucleotide and amino acid composition. Discriminant analysis separated overlapping from non-overlapping genes with an accuracy of 97%. When applied to overlapping genes with known genealogy, it separated ancestral from de novo frames with an accuracy close to 100%. This high discriminant power was crucial to computationally design variants of de novo viral proteins known to possess selective anticancer toxicity (apoptin) or protection against neurodegeneration (X protein), as well as to detect two new potential overlapping genes in the genome of the new coronavirus SARS-CoV-2.","Virology","Pavesi, Angelo","32452417"],"abstract":["Overlapping genes originate by a mechanism of overprinting, in which nucleotide substitutions in a pre-existing frame induce the expression of a de novo protein from an alternative frame. In this study, I assembled a dataset of 319 viral overlapping genes, which included 82 overlaps whose expression is experimentally known and the respective 237 homologs. Principal component analysis revealed that overlapping genes have a common pattern of nucleotide and amino acid composition. Discriminant analysis separated overlapping from non-overlapping genes with an accuracy of 97%. When applied to overlapping genes with known genealogy, it separated ancestral from de novo frames with an accuracy close to 100%. This high discriminant power was crucial to computationally design variants of de novo viral proteins known to possess selective anticancer toxicity (apoptin) or protection against neurodegeneration (X protein), as well as to detect two new potential overlapping genes in the genome of the new coronavirus SARS-CoV-2."],"journal":"Virology","authors":["Pavesi, Angelo"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452417","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.virol.2020.03.007","keywords":["ancestral reading frame","apoptin","codon usage","computer simulation","de novo reading frame","homologs","multivariate statistics","sars-cov-2","therapeutic proteins","virus evolution"],"topics":["Mechanism"],"weight":1,"_version_":1667881798581878784,"score":9.490897,"similar":[{"pmid":32473977,"title":"Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.","text":["Unfolding SARS-CoV-2 viral genome to understand its gene expression regulation.","SARS-CoV-2 is a new virus responsible for an outbreak of respiratory illness known as COVID-19, which has spread to several countries around the world and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In silico analysis of the transcription start sites, promoter regions, transcription factors and their binding sites, gene ontology, CpG islands for SARS-CoV-2 viral genome are a first step to understand the regulation mechanisms of gene expression and association with genetic variations in the genomes. For this purpose, we first computationally surveyed all SARS-CoV-2 virus genes with the open reading frames from NCBI database and found eleven sequences to accomplish the mentioned features by using bioinformatics tools. Our analysis revealed that all (100%) of the SARS-CoV-2 virus genes have more than one TSS. By taking all TSSs with the highest predictive score we determined promoter regions and identified five common candidate motifs (MVI, MVII, MVIII, MVIV and MVV) of which MVI was found to be shared by all promoter regions of SARS-CoV-2 virus genes with the least E-value (3.8e-056, statistically highly significant). In our further analysis of MVI we showed MVI serve as binding sites for a single transcription factor (TF) family, EXPREG, involved in the regulatory mode of these genes. From EXPREG family four TFs that belongs to Cyclic AMP (cAMP) receptor protein (CRP) and Catabolite control protein A (CcpA) group mostly serve as transcriptional activator whereas two TFs that belong to LexA group always serve as transcriptional repressor in different kinds of cellular processes and molecular functions. Therefore, we unfolded SARS-CoV-2 viral genome to shed light on its gene expression regulation that could help to design and evaluate diagnostic tests, to track and trace the ongoing outbreak and to identify potential intervention options.","Infect Genet Evol","Dinka, Hunduma","Milkesa, Ashenafi","32473977"],"abstract":["SARS-CoV-2 is a new virus responsible for an outbreak of respiratory illness known as COVID-19, which has spread to several countries around the world and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus. In silico analysis of the transcription start sites, promoter regions, transcription factors and their binding sites, gene ontology, CpG islands for SARS-CoV-2 viral genome are a first step to understand the regulation mechanisms of gene expression and association with genetic variations in the genomes. For this purpose, we first computationally surveyed all SARS-CoV-2 virus genes with the open reading frames from NCBI database and found eleven sequences to accomplish the mentioned features by using bioinformatics tools. Our analysis revealed that all (100%) of the SARS-CoV-2 virus genes have more than one TSS. By taking all TSSs with the highest predictive score we determined promoter regions and identified five common candidate motifs (MVI, MVII, MVIII, MVIV and MVV) of which MVI was found to be shared by all promoter regions of SARS-CoV-2 virus genes with the least E-value (3.8e-056, statistically highly significant). In our further analysis of MVI we showed MVI serve as binding sites for a single transcription factor (TF) family, EXPREG, involved in the regulatory mode of these genes. From EXPREG family four TFs that belongs to Cyclic AMP (cAMP) receptor protein (CRP) and Catabolite control protein A (CcpA) group mostly serve as transcriptional activator whereas two TFs that belong to LexA group always serve as transcriptional repressor in different kinds of cellular processes and molecular functions. Therefore, we unfolded SARS-CoV-2 viral genome to shed light on its gene expression regulation that could help to design and evaluate diagnostic tests, to track and trace the ongoing outbreak and to identify potential intervention options."],"journal":"Infect Genet Evol","authors":["Dinka, Hunduma","Milkesa, Ashenafi"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32473977","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.meegid.2020.104386","keywords":["covid-19","cpg island","motif","promoter","sars-cov-2","transcription factor"],"locations":["MVII"],"topics":["Mechanism"],"weight":1,"_version_":1668341932745555968,"score":321.67148},{"pmid":32433742,"title":"Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.","text":["Extended ORF8 Gene Region Is Valuable in the Epidemiological Investigation of SARS-similar Coronavirus.","Severe acute respiratory syndrome Coronavirus (SARS-CoV) was discovered as a novel pathogen in the 2002-2003 SARS epidemic. The emergence and disappearance of this pathogen have brought questions regarding its source and evolution. Within the genome sequences of 281 SARS-CoVs, SARS-CoV-2, and SARSr-CoVs, a ~430 bp genomic region (from 27701bp to 28131bp in AY390556.1) with regular variations was investigated. This ~430 bp region overlaps with the ORF8 gene and is prone to deletions and nucleotide substitutions. Its complexity suggested the need for a new genotyping method for Coronavirus related to SARS-similar Coronavirus (SARS-CoV, SARSr-CoV and SARS-CoV-2). Bat SARSr-CoV presented three genotypes, of which Type 0 is only seen in Bat SARSr-CoV, Type I is present in SARS early phase and Type II is found in all SARS-CoV-2. This genotyping also shows potential usage in distinguishing the SARS-similar Coronaviruses from different hosts and geographic areas. This genomic region has important implications for predicting the epidemic trend and studying the evolution of Coronavirus.","J Infect Dis","Chen, Shuaiyin","Zheng, Xin","Zhu, Jingyuan","Ding, Ronghua","Jin, Yuefei","Zhang, Weiguo","Yang, HaiYan","Zheng, Yingjuan","Li, Xin","Duan, Guangcai","32433742"],"abstract":["Severe acute respiratory syndrome Coronavirus (SARS-CoV) was discovered as a novel pathogen in the 2002-2003 SARS epidemic. The emergence and disappearance of this pathogen have brought questions regarding its source and evolution. Within the genome sequences of 281 SARS-CoVs, SARS-CoV-2, and SARSr-CoVs, a ~430 bp genomic region (from 27701bp to 28131bp in AY390556.1) with regular variations was investigated. This ~430 bp region overlaps with the ORF8 gene and is prone to deletions and nucleotide substitutions. Its complexity suggested the need for a new genotyping method for Coronavirus related to SARS-similar Coronavirus (SARS-CoV, SARSr-CoV and SARS-CoV-2). Bat SARSr-CoV presented three genotypes, of which Type 0 is only seen in Bat SARSr-CoV, Type I is present in SARS early phase and Type II is found in all SARS-CoV-2. This genotyping also shows potential usage in distinguishing the SARS-similar Coronaviruses from different hosts and geographic areas. This genomic region has important implications for predicting the epidemic trend and studying the evolution of Coronavirus."],"journal":"J Infect Dis","authors":["Chen, Shuaiyin","Zheng, Xin","Zhu, Jingyuan","Ding, Ronghua","Jin, Yuefei","Zhang, Weiguo","Yang, HaiYan","Zheng, Yingjuan","Li, Xin","Duan, Guangcai"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32433742","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/infdis/jiaa278","keywords":["orf8 gene","sars-cov","sars-cov-2","genotyping method"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1667342288175497216,"score":292.94708},{"pmid":32503821,"title":"SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.","text":["SARS-CoV-2 orf1b Gene Sequence in the NTNG1 Gene on Human Chromosome 1.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19) pandemic. In the current analysis, we searched for SARS-CoV-2 sequences within the human genome. To compare the SARS-CoV-2 genome to the human genome, we used the blast-like alignment tool (BLAT) of the University of California, Santa Cruz Genome Browser. BLAT can align a user sequence of 25 bases or more to the genome. BLAT search results revealed a 117-base pair SARS-CoV-2 sequence in the human genome with 94.6% identity. The sequence was in chromosome 1p within an intronic region of the netrin G1 (NTNG1) gene. The sequence matched a sequence in the SARS-CoV-2 orf1b (open reading frames) gene. The SARS-CoV-2 human sequence lies within non-structural proteins 14 and 15 (NSP14 and NSP15), and is quite close to the viral spike sequence, separated only by NSP16, a 904-base pair sequence. The mechanism for SARS-CoV-2 infection is the binding of the virus spike protein to the membrane-bound form of angiotensin-converting enzyme 2 and internalization of the complex by the host cell. It is probably no accident that a sequence from the SARS-CoV-2 orf1b gene is found in the human NTNG1 gene, implicated in schizophrenia, and that haloperidol, used to treat schizophrenia, may also be a treatment for COVID-19. We suggest, therefore, that it is important to investigate other haloperidol analogs. Among them are benperidol, bromperidol, bromperidol decanoate, droperidol, seperidol hydrochloride, and trifluperidol. These analogs might be valuable in the treatment of COVID-19 and other coronavirus infections.","In Vivo","Lehrer, Steven","Rheinstein, Peter H","32503821"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus. It is contagious in humans and is the cause of the coronavirus disease 2019 (COVID-19) pandemic. In the current analysis, we searched for SARS-CoV-2 sequences within the human genome. To compare the SARS-CoV-2 genome to the human genome, we used the blast-like alignment tool (BLAT) of the University of California, Santa Cruz Genome Browser. BLAT can align a user sequence of 25 bases or more to the genome. BLAT search results revealed a 117-base pair SARS-CoV-2 sequence in the human genome with 94.6% identity. The sequence was in chromosome 1p within an intronic region of the netrin G1 (NTNG1) gene. The sequence matched a sequence in the SARS-CoV-2 orf1b (open reading frames) gene. The SARS-CoV-2 human sequence lies within non-structural proteins 14 and 15 (NSP14 and NSP15), and is quite close to the viral spike sequence, separated only by NSP16, a 904-base pair sequence. The mechanism for SARS-CoV-2 infection is the binding of the virus spike protein to the membrane-bound form of angiotensin-converting enzyme 2 and internalization of the complex by the host cell. It is probably no accident that a sequence from the SARS-CoV-2 orf1b gene is found in the human NTNG1 gene, implicated in schizophrenia, and that haloperidol, used to treat schizophrenia, may also be a treatment for COVID-19. We suggest, therefore, that it is important to investigate other haloperidol analogs. Among them are benperidol, bromperidol, bromperidol decanoate, droperidol, seperidol hydrochloride, and trifluperidol. These analogs might be valuable in the treatment of COVID-19 and other coronavirus infections."],"journal":"In Vivo","authors":["Lehrer, Steven","Rheinstein, Peter H"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503821","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.21873/invivo.11953","keywords":["covid-19","ntng1 gene","haloperidol","orf1b gene","the ucsc genome browser"],"e_drugs":["Droperidol","Trifluperidol","bromperidol","bromperidol decanoate","Haloperidol","Benperidol"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668892488210841601,"score":259.35544},{"pmid":32159237,"title":"From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.","text":["From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.","BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of SARS-CoV-2 and the changes in SARS-CoV-2 in comparison with the two prior major COV epidemics, SARS and Middle East respiratory syndrome (MERS) coronaviruses. METHODS: The genome composition, nucleotide analysis, codon usage indices, relative synonymous codons usage, and effective number of codons (ENc) were analyzed in the four structural genes; Spike (S), Envelope (E), membrane (M), and Nucleocapsid (N) genes, and two of the most important nonstructural genes comprising RNA-dependent RNA polymerase and main protease (Mpro) of SARS-CoV-2, Beta-CoV from pangolins, bat SARS, MERS, and SARS CoVs. RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines. Most high-frequency codons were ending with A or T, while the low frequency and rare codons were ending with G or C. SARS-CoV-2 structural proteins showed 5 to 20 lower ENc values, compared with SARS, bat SARS, and MERS CoVs. This implies higher codon bias and higher gene expression efficiency of SARS-CoV-2 structural proteins. SARS-CoV-2 encoded the highest number of over-biased and negatively biased codons. Pangolin Beta-CoV showed little differences with SARS-CoV-2 ENc values, compared with SARS, bat SARS, and MERS CoV. CONCLUSION: Extreme bias and lower ENc values of SARS-CoV-2, especially in Spike, Envelope, and Mpro genes, are suggestive for higher gene expression efficiency, compared with SARS, bat SARS, and MERS CoVs.","J Med Virol","Kandeel, Mahmoud","Ibrahim, Abdelazim","Fayez, Mahmoud","Al-Nazawi, Mohammed","32159237"],"abstract":["BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging disease with fatal outcomes. In this study, a fundamental knowledge gap question is to be resolved by evaluating the differences in biological and pathogenic aspects of SARS-CoV-2 and the changes in SARS-CoV-2 in comparison with the two prior major COV epidemics, SARS and Middle East respiratory syndrome (MERS) coronaviruses. METHODS: The genome composition, nucleotide analysis, codon usage indices, relative synonymous codons usage, and effective number of codons (ENc) were analyzed in the four structural genes; Spike (S), Envelope (E), membrane (M), and Nucleocapsid (N) genes, and two of the most important nonstructural genes comprising RNA-dependent RNA polymerase and main protease (Mpro) of SARS-CoV-2, Beta-CoV from pangolins, bat SARS, MERS, and SARS CoVs. RESULTS: SARS-CoV-2 prefers pyrimidine rich codons to purines. Most high-frequency codons were ending with A or T, while the low frequency and rare codons were ending with G or C. SARS-CoV-2 structural proteins showed 5 to 20 lower ENc values, compared with SARS, bat SARS, and MERS CoVs. This implies higher codon bias and higher gene expression efficiency of SARS-CoV-2 structural proteins. SARS-CoV-2 encoded the highest number of over-biased and negatively biased codons. Pangolin Beta-CoV showed little differences with SARS-CoV-2 ENc values, compared with SARS, bat SARS, and MERS CoV. CONCLUSION: Extreme bias and lower ENc values of SARS-CoV-2, especially in Spike, Envelope, and Mpro genes, are suggestive for higher gene expression efficiency, compared with SARS, bat SARS, and MERS CoVs."],"journal":"J Med Virol","authors":["Kandeel, Mahmoud","Ibrahim, Abdelazim","Fayez, Mahmoud","Al-Nazawi, Mohammed"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32159237","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25754","keywords":["covid-19","mers cov","sars-cov-2","codon bias","nonstructural protein","preferred codons"],"locations":["Spike"],"e_drugs":["pyrimidine","Purines"],"topics":["Mechanism"],"weight":1,"_version_":1666138490659667969,"score":237.10042},{"pmid":32492203,"title":"Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.","text":["Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.","Recent days have seen growing evidence of cancer's susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the effect of genomic differences on the virus' entrance genes in lung cancer. Genetic confirmation of the hypotheses regarding gene expression and mutation pattern of target genes, including Angiotensin Converting Enzyme-2 (ACE2), Transmembrane Serine Protease 2 (TMPRSS2), Basigin (CD147/BSG) and Paired Basic Amino Acid Cleaving Enzyme (FURIN/PCSK3), as well as correlation analysis, were evaluated in lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC) using in silico analysis. Not only were gene expression and mutation patterns detected, but also there was a correlation and survival analysis between ACE2 and other target genes expression levels. The total genetic anomaly carrying rate of target genes, including ACE2, TMPRSS2, CD147/BSG and FURIN/PCSK3, was determined as 8.1% and 21 mutations detected, with 7 of these mutations having pathogenic features. p.H34N on the RBD binding residues for SARS-CoV-2 was determined in our LUAD patient group. According to gene expression analysis results in LUAD and LUSC patient groups, while the TMPRSS2 level was statistically significantly decreased in the LUSC patient group compared to healthy control, the ACE2 level was determined to be high in LUAD and LUSC. There were no meaningful differences in expression of CD147 and FURIN genes. The challenge for the today is building the assessment of genomic susceptibility to COVID-19 in lung cancer, requiring detailed experimental laboratory studies, in addition to in silico analyses, as a way of assessing the mechanism of novel virus invasion that can be used in the development of effective SARS-CoV-2 therapy. This article is protected by copyright. All rights reserved.","J Med Virol","Sagkan, Rahsan Ilikci","Akin-Bali, Dilara Fatma","32492203"],"abstract":["Recent days have seen growing evidence of cancer's susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and of the effect of genomic differences on the virus' entrance genes in lung cancer. Genetic confirmation of the hypotheses regarding gene expression and mutation pattern of target genes, including Angiotensin Converting Enzyme-2 (ACE2), Transmembrane Serine Protease 2 (TMPRSS2), Basigin (CD147/BSG) and Paired Basic Amino Acid Cleaving Enzyme (FURIN/PCSK3), as well as correlation analysis, were evaluated in lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC) using in silico analysis. Not only were gene expression and mutation patterns detected, but also there was a correlation and survival analysis between ACE2 and other target genes expression levels. The total genetic anomaly carrying rate of target genes, including ACE2, TMPRSS2, CD147/BSG and FURIN/PCSK3, was determined as 8.1% and 21 mutations detected, with 7 of these mutations having pathogenic features. p.H34N on the RBD binding residues for SARS-CoV-2 was determined in our LUAD patient group. According to gene expression analysis results in LUAD and LUSC patient groups, while the TMPRSS2 level was statistically significantly decreased in the LUSC patient group compared to healthy control, the ACE2 level was determined to be high in LUAD and LUSC. There were no meaningful differences in expression of CD147 and FURIN genes. The challenge for the today is building the assessment of genomic susceptibility to COVID-19 in lung cancer, requiring detailed experimental laboratory studies, in addition to in silico analyses, as a way of assessing the mechanism of novel virus invasion that can be used in the development of effective SARS-CoV-2 therapy. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Sagkan, Rahsan Ilikci","Akin-Bali, Dilara Fatma"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32492203","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1002/jmv.26107","keywords":["ace2","cd147","covid-19","furin","severe acute respiratory syndrome coronavirus 2","tmprss2","lung cancer"],"locations":["LUAD","LUSC","LUSC","LUAD","Lung"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668623433714368512,"score":236.32994}]}